Avelumab in Combination With Hypofractionated Radiotherapy in Patients With Relapsed Refractory Multiple Myeloma

NCT03910439 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

4

Enrollment

NIH

Sponsor class

Stopped Slow/Insufficient accrual/COVID-19 pandemic

Conditions

Myeloma, Multiple
Myeloma-Multiple

Interventions

BIOLOGICAL: Avelumab
RADIATION: External beam radiotherapy

Sponsor

National Cancer Institute (NCI)